nuclear pkm2 regulates beta-catenin transactivation upon egfr activation 
embryonic pyruvate kinase m2 pkm2 isoform highly expressed human cancer contrast established role pkm2 aerobic glycolysis warburg effect1- non-metabolic functions remain elusive demonstrate human cancer cells epidermal growth factor receptor egfr activation induces translocation pkm2 pkm1 nucleus k433 pkm2 binds c-src-phosphorylated y333 beta-catenin interaction required proteins recruited ccnd1 promoter leading hdac3 removal promoter histone h3 acetylation cyclin d1 expression pkm2-dependent beta-catenin transactivation instrumental egfr-promoted tumour cell proliferation brain tumour development addition positive correlations identified c-src activity beta-catenin y333 phosphorylation pkm2 nuclear accumulation human glioblastoma specimens furthermore levels beta-catenin phosphorylation nuclear pkm2 correlated grades glioma malignancy prognosis findings reveal egf induces beta-catenin transactivation via mechanism distinct induced wnt/wingless4 highlight essential non-metabolic functions pkm2 egfr-promoted beta-catenin transactivation cell proliferation tumorigenesis 
